Tekmira Pharmaceuticals Corporation
TSX : TKM

Tekmira Pharmaceuticals Corporation

November 30, 2009 23:53 ET

Tekmira Pharmaceuticals to Webcast Presentation at the Piper Jaffray Health Care Conference

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 30, 2009) - Tekmira Pharmaceuticals Corporation (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics and proprietary delivery technology, announced today that the Company's President and Chief Executive Officer, Dr. Mark Murray, will present at the Piper Jaffray 21st Annual Health Care Conference on Tuesday December 1, 2009 at 9:30 am ET at the New York Palace Hotel in New York City. A webcast of the presentation will be available and can be accessed on the Company's website, www.tekmirapharm.com.

About Tekmira

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Further information about Tekmira can be found at www.tekmirapharm.com. Tekmira is based in Vancouver, B.C.

Contact Information

  • The Equicom Group
    Adam Peeler
    Investor Contact
    416-815-0700 x 225
    apeeler@equicomgroup.com
    or
    Tekmira Pharmaceuticals Corporation
    Ian Mortimer
    Executive Vice President and Chief Financial Officer
    604-419-3200
    or
    Longview Communications Inc.
    David Ryan
    Media Contact
    604-694-6031
    dryan@longviewcomms.ca